Amgen
AMGN
1,749 hedge funds and large institutions have $90B invested in Amgen in 2018 Q1 according to their latest regulatory filings, with 126 funds opening new positions, 647 increasing their positions, 765 reducing their positions, and 91 closing their positions.
38% more first-time investments, than exits
New positions opened: 126 | Existing positions closed: 91
18% more funds holding in top 10
Funds holding in top 10: 61 → 72 (+11)
1% more funds holding
Funds holding: 1,734 → 1,749 (+15)
5.88% less ownership
Funds ownership: 79.17% → 73.29% (-5.9%)
10% less capital invested
Capital invested by funds: $99.9B → $90B (-$9.9B)
15% less repeat investments, than reductions
Existing positions increased: 647 | Existing positions reduced: 765
30% less call options, than puts
Call options by funds: $795M | Put options by funds: $1.13B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pzena Investment Management
New York
|
+$246M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$201M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$176M |
| 4 |
Barclays
London,
United Kingdom
|
+$140M |
| 5 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$86.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.65B |
| 2 |
State Street
Boston,
Massachusetts
|
-$763M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$714M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$595M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$527M |
AMGN Hedge Fund Activity: Q1 2018 in Review
1,749 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2018, worth a combined $90B — down 9.9% from $99.9B a quarter earlier.
Buyers outnumbered sellers: 126 funds opened new AMGN positions and 91 closed out — a net gain of 35 holders — while 647 added to existing stakes and 765 trimmed.
The largest buyer was Pzena Investment Management, adding an estimated $246M. The largest seller was Fidelity Investments, cutting an estimated $1.65B.
- 1,749 institutional investors held Amgen (AMGN) as of Q1 2018, up from 1,734 in Q4 2017.
- Funds reported $90B of Amgen stock for Q1 2018, down 9.9% quarter-over-quarter.
- 126 funds opened new Amgen positions in Q1 2018 and 91 closed out, a net change of +35 holders.
- The largest Amgen buyer in Q1 2018 was Pzena Investment Management, an estimated $246M added.
- The largest Amgen seller in Q1 2018 was Fidelity Investments, an estimated $1.65B sold.
Based on aggregated 13F filings for Q1 2018.